XML 58 R42.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
12 Months Ended
Jul. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based awards outstanding by award type
As of July 31, 2025, the following stock-based awards, by award type, were outstanding:
 July 31, 2025
Stock options124,470 
Performance shares593,680 
RSUs, restricted stock, share units and other stock-based awards1,081,425 
Total1,799,575 
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Consolidated Statements of Operations:
 Fiscal Years Ended July 31,
 202520242023
Cost of sales$392,000 778,000 1,110,000 
Selling, general and administrative expenses2,479,000 4,777,000 7,960,000 
Research and development expenses249,000 541,000 1,037,000 
Stock-based compensation expense before CEO transition
     costs
3,120,000 6,096,000 10,107,000 
CEO transition costs related to equity-classified stock-based
     awards
— — 3,764,000 
Total stock-based compensation expense before income tax
     benefit
3,120,000 6,096,000 13,871,000 
Estimated income tax benefit— (1,298,000)(2,552,000)
Net stock-based compensation expense$3,120,000 4,798,000 11,319,000 
Summary of stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
Fiscal Years Ended July 31,
202520242023
Stock options$29,000 60,000 87,000 
Performance shares72,000 480,000 973,000 
RSUs, restricted stock, share units and other stock-based awards2,973,000 5,477,000 8,926,000 
ESPP46,000 79,000 121,000 
Stock based compensation expense before CEO transition costs3,120,000 6,096,000 10,107,000 
CEO transition costs related to equity-classified stock-based
    awards
— — 3,764,000 
Total stock-based compensation expense before income tax benefit3,120,000 6,096,000 13,871,000 
Estimated income tax benefit— (1,298,000)(2,552,000)
Net stock-based compensation expense$3,120,000 4,798,000 11,319,000 
Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity:
 Awards
(in Shares)
Weighted Average
Exercise Price
Weighted Average
Remaining Contractual
Term (Years)
Aggregate
Intrinsic Value
Outstanding at July 31, 2022483,480 $24.43   
Expired/canceled(242,970)24.89   
Outstanding at July 31, 2023240,510 23.96 
Expired/canceled(99,320)28.72 
Outstanding at July 31, 2024141,190 20.61 
Expired/canceled(16,720)21.77 
Outstanding at July 31, 2025124,470 $20.45 3.57$— 
Exercisable at July 31, 2025124,470 $20.45 3.57$— 
Vested and expected to vest at July 31, 2025124,470 $20.45 3.57$— 
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock, share units and other stock-based awards:
  Awards
(in Shares)
 Weighted Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2022 1,110,750 $19.05 
Granted 1,550,951 10.79 
Settled (632,267)16.69 
Canceled/Forfeited (153,204)16.67 
Outstanding at July 31, 20231,876,230 13.21 
Granted1,731,760 6.71 
Settled(1,042,860)9.77 
Canceled/Forfeited(764,842)9.28 
Outstanding at July 31, 2024 1,800,288 10.61 
Granted1,677,677 4.57 
Settled(855,870)9.37 
Canceled/Forfeited(946,990)6.54 
Outstanding at July 31, 20251,675,105 $6.53 $3,635,000 
  
Vested at July 31, 2025 122,554 $13.03 $266,000 
  
Vested and expected to vest at July 31, 2025 1,632,321 $6.61 $3,542,000